Hipit Putri Apriasih, Andri Nofreeana, Eric Armando
{"title":"评估蕨类植物作为抗糖尿病剂和食品添加剂的潜力","authors":"Hipit Putri Apriasih, Andri Nofreeana, Eric Armando","doi":"10.15578//jpbkp.v18i2.935","DOIUrl":null,"url":null,"abstract":"Food is a factor that can increase blood glucose levels or cause diabetes mellitus (DM). DM can be treated with traditional medicines from plants that contain anti-diabetic compounds such as flavonoids. These flavonoids play a role in inhibiting the activity of the α-glycosidase enzyme so that they can inhibit the increase in blood glucose levels.. Flavonoid compounds exist in several types of Caulerpa sp. such as C. serrulata, C. racemosa, and C. lentillifera. The purpose of this study was to determine the antidiabetic potential of C. serrulata, C. racemosa, and C. lentillifera flour. In this study Caulerpa flour was substituted in noodles and tested on rats. Parameters tested included blood glucose levels, body weight and glycemic index. The method used was a 2-factorial completely randomized design (CRD) with factor 1 being Caulerpa type and factor 2 being dose size. The glucose level data obtained was analyzed statistically using variance (ANOVA) with a significance level of 5% and if the treatment of the observed variables showed differences then it was continued with the Duncan's Multiple Range Test (DMRT) while the glycemic index analysis was determined by comparing the area under curve (Area Under Curve or AUC) Caulerpa noodles and glucose. The results of the analysis of blood glucose levels showed that the treatment that was given Caulerpa flour experienced a decrease in blood glucose levels in rats. The best results for reducing glucose levels were shown in the C1D2 treatment (C. serrulata dose of 15%) with a decrease of 44.58%. The different types of Caulerpa did not show a significant difference, while the dose treatment showed a significant difference. The results of the analysis of the rats' body weight showed that the average had decreased. Whereas in the glycemic index test results, the smallest GI value was 37.9 in the C3D1 treatment (C. lentillifera dose of 10%).","PeriodicalId":31542,"journal":{"name":"Jurnal Pascapanen dan Bioteknologi Kelautan dan Perikanan","volume":"60 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluasi Potensi Jenis Caulerpa sebagai Agen Antidiabetik dan Sediaan Fortifikasi dalam Pangan\",\"authors\":\"Hipit Putri Apriasih, Andri Nofreeana, Eric Armando\",\"doi\":\"10.15578//jpbkp.v18i2.935\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Food is a factor that can increase blood glucose levels or cause diabetes mellitus (DM). DM can be treated with traditional medicines from plants that contain anti-diabetic compounds such as flavonoids. These flavonoids play a role in inhibiting the activity of the α-glycosidase enzyme so that they can inhibit the increase in blood glucose levels.. Flavonoid compounds exist in several types of Caulerpa sp. such as C. serrulata, C. racemosa, and C. lentillifera. The purpose of this study was to determine the antidiabetic potential of C. serrulata, C. racemosa, and C. lentillifera flour. In this study Caulerpa flour was substituted in noodles and tested on rats. Parameters tested included blood glucose levels, body weight and glycemic index. The method used was a 2-factorial completely randomized design (CRD) with factor 1 being Caulerpa type and factor 2 being dose size. The glucose level data obtained was analyzed statistically using variance (ANOVA) with a significance level of 5% and if the treatment of the observed variables showed differences then it was continued with the Duncan's Multiple Range Test (DMRT) while the glycemic index analysis was determined by comparing the area under curve (Area Under Curve or AUC) Caulerpa noodles and glucose. The results of the analysis of blood glucose levels showed that the treatment that was given Caulerpa flour experienced a decrease in blood glucose levels in rats. The best results for reducing glucose levels were shown in the C1D2 treatment (C. serrulata dose of 15%) with a decrease of 44.58%. The different types of Caulerpa did not show a significant difference, while the dose treatment showed a significant difference. The results of the analysis of the rats' body weight showed that the average had decreased. Whereas in the glycemic index test results, the smallest GI value was 37.9 in the C3D1 treatment (C. lentillifera dose of 10%).\",\"PeriodicalId\":31542,\"journal\":{\"name\":\"Jurnal Pascapanen dan Bioteknologi Kelautan dan Perikanan\",\"volume\":\"60 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal Pascapanen dan Bioteknologi Kelautan dan Perikanan\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15578//jpbkp.v18i2.935\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Pascapanen dan Bioteknologi Kelautan dan Perikanan","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15578//jpbkp.v18i2.935","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
食物是导致血糖水平升高或引发糖尿病(DM)的一个因素。糖尿病可以用传统药物治疗,这些药物来自含有抗糖尿病化合物(如类黄酮)的植物。这些类黄酮具有抑制α-糖苷酶活性的作用,因此可以抑制血糖水平的升高。黄酮类化合物存在于几种类型的 Caulerpa sp.中,如 C. serrulata、C. racemosa 和 C. lentillifera。本研究的目的是确定 C.serrulata、C.racemosa 和 C.lentillifera面粉的抗糖尿病潜力。在这项研究中,用 Caulerpa 粉代替面条,并对大鼠进行了测试。测试参数包括血糖水平、体重和血糖生成指数。采用的方法是双因子完全随机设计(CRD),因子 1 是菜豆类型,因子 2 是剂量大小。获得的血糖水平数据采用方差分析(ANOVA)进行统计分析,显著性水平为 5%,如果观察到的变量的处理出现差异,则继续采用邓肯多范围检验(DMRT),而血糖生成指数分析则通过比较草决明面和葡萄糖的曲线下面积(Area Under Curve 或 AUC)来确定。血糖水平分析结果表明,服用草果粉的大鼠血糖水平有所下降。C1D2 处理(C. serrulata 剂量为 15%)降低血糖水平的效果最好,降低了 44.58%。不同类型的蛇莓没有显示出显著差异,而剂量处理则显示出显著差异。对大鼠体重的分析结果显示,平均体重有所下降。而在血糖生成指数测试结果中,C3D1 处理(C. lentillifera 剂量为 10%)的 GI 值最小,为 37.9。
Evaluasi Potensi Jenis Caulerpa sebagai Agen Antidiabetik dan Sediaan Fortifikasi dalam Pangan
Food is a factor that can increase blood glucose levels or cause diabetes mellitus (DM). DM can be treated with traditional medicines from plants that contain anti-diabetic compounds such as flavonoids. These flavonoids play a role in inhibiting the activity of the α-glycosidase enzyme so that they can inhibit the increase in blood glucose levels.. Flavonoid compounds exist in several types of Caulerpa sp. such as C. serrulata, C. racemosa, and C. lentillifera. The purpose of this study was to determine the antidiabetic potential of C. serrulata, C. racemosa, and C. lentillifera flour. In this study Caulerpa flour was substituted in noodles and tested on rats. Parameters tested included blood glucose levels, body weight and glycemic index. The method used was a 2-factorial completely randomized design (CRD) with factor 1 being Caulerpa type and factor 2 being dose size. The glucose level data obtained was analyzed statistically using variance (ANOVA) with a significance level of 5% and if the treatment of the observed variables showed differences then it was continued with the Duncan's Multiple Range Test (DMRT) while the glycemic index analysis was determined by comparing the area under curve (Area Under Curve or AUC) Caulerpa noodles and glucose. The results of the analysis of blood glucose levels showed that the treatment that was given Caulerpa flour experienced a decrease in blood glucose levels in rats. The best results for reducing glucose levels were shown in the C1D2 treatment (C. serrulata dose of 15%) with a decrease of 44.58%. The different types of Caulerpa did not show a significant difference, while the dose treatment showed a significant difference. The results of the analysis of the rats' body weight showed that the average had decreased. Whereas in the glycemic index test results, the smallest GI value was 37.9 in the C3D1 treatment (C. lentillifera dose of 10%).